Your browser doesn't support javascript.
loading
A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study.
Rana, Vandana; Ranjan, Praveer; Jagani, Rajat; Rathi, K R; Kumar, Dharmesh; Khera, Anurag.
  • Rana V; Classified Specialist (Pathology), Command Hospital (Southern Command), Pune 411040, India.
  • Ranjan P; Senior Adviser (Pathology), Command Hospital (Southern Command), Pune 411040, India.
  • Jagani R; Senior Adviser (Pathology), Command Hospital (Southern Command), Pune 411040, India.
  • Rathi KR; Head of Department & Senior Adviser (Path & Neuropath), Command Hospital (Southern Command), Pune 411040, India.
  • Kumar D; Senior Adviser (Medicine) & Oncologist, Malignant Disease Treatment Centre, Command Hospital (Southern Command), Pune 411040, India.
  • Khera A; Assistant Professor, Department of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Med J Armed Forces India ; 74(2): 148-153, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29692481
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article